Plaque Psoriasis

Ustekinumab Associated with Increased Risk of Serious Cardiovascular Events

September 18, 2020

Ustekinumab should be prescribed cautiously to those at high cardiovascular risk.

Ashley Crew, MD: Clinical Manifestations in Rheum Care Requiring Derm Consult

September 12, 2020

When a rheum patient might need to consult with a dermatologist.

Age Should Not Be Factor in Effective Psoriasis Management

August 20, 2020

More studies are needed on the effectiveness and safety of plaque psoriasis therapies for older patients.

FDA Expands Ustekinumab to Pediatric Plaque Psoriasis

July 31, 2020

The expansion makes history for the injection biologic.

Netakimab Rapidly Improves Axial Disease

June 05, 2020

The findings are based on data from a 24-week observation from an ongoing phase 3 PATERA study.

Biologics Do Not Increase Melanoma Risk in Patients With Inflammatory Disease

May 20, 2020

There is no significant association between biologic exposure and the development of melanoma in patients with IBD, rheumatoid arthritis, or psoriasis.

Top-Line Results Positive for New Plaque Psoriasis Treatment

May 08, 2020

Investigators found 30 mg of apremilast results in a significant reduction in plaque psoriasis patients.

Psoriasis Patients with Mental Illness Report Worse Clinical Interaction

May 06, 2020

An assessment of survey data show patients with severe depressive or psychological symptoms are more likely to be dissatisfied with their dermatologist.

How COVID-19 Affects Dermatology

May 05, 2020

A dermatologist discusses how to care for patients with psoriasis during the COVID-19 pandemic.

Ixekizumab Continues to Build Chronic Care Portfolio

April 15, 2020

The IL-17A-targeting biologic has now been indicated for pediatric plaque psoriasis—marking its fourth indication for patients with chronic diseases.